Crosstalk between B16 melanoma cells and B-1 lymphocytes induces global changes in tumor cell gene expression

Immunobiology

Volumn 218, Issue 10, 2013, Pages 1293-1303

  Xander, Patricia ^a   Brito, Ronni RÔmulo Novaes e ^b   Pérez, Elizabeth Cristina ^c   Pozzibon, Jaqueline Maciel ^a   de Souza, Camila Ferreira ^a   Pellegrino, Renata ^a   Bernardo, Viviane ^a   Jasiulionis, Miriam Galvonas ^a   Mariano, Mario ^a   Lopes, José Daniel ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro Universitario Sao Camilo   (Brazil)

^c PAULISTA UNIVERSITY   (Brazil)

Author keywords

B 1 cells; Gene expression; Melanoma; Metastases; Microarray

Indexed keywords

CXCL2 CHEMOKINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RANTES; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CCL5 GENE; CONTROLLED STUDY; CTSS GENE; CXCL2 GENE; GENE; GENE EXPRESSION; MELANOMA CELL; METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAT3 GENE; UPREGULATION; WESTERN BLOTTING;

B-1 CELLS; GENE EXPRESSION; MELANOMA; METASTASES; MICROARRAY;

ANIMALS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CATHEPSINS; CELL COMMUNICATION; CHEMOKINE CCL5; CHEMOKINE CXCL12; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MAP KINASE SIGNALING SYSTEM; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; NEOPLASM METASTASIS; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED;

EID: 84881022960     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.04.017     Document Type: Article

References (52)

1. Aggarwal B.B., Kunnumakkara A.B., Harikumar K.B., Gupta S.R., Tharakan S.T., Koca C., Dey S., Sung B. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann. N. Y. Acad. Sci. 2009, 1171:59-76.
2. Almeida S.R., Aroeira L.S., Frymuller E., Dias M.A., Bogsan C.S., Lopes J.D., Mariano M. Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute non-specific inflammatory exudate. Int. Immunol. 2001, 13:1193-1201.
3. Bachmeier B.E., Mohrenz I.V., Mirisola V., Schleicher E., Romeo F., Höhneke C., Jochum M., Nerlich A.G., Pfeffer U. Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis 2008, 29:779-789.
4. Balkwill F.R., Mantovani A. Cancer-related inflammation: common themes and therapeutic opportunities. Semin. Cancer Biol. 2012, 22:33-40.
5. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
7. Buettner R., Mora L.B., Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 2002, 8:945-954.
8. Burden R.E., Gormley J.A., Jaquin T.J., Small D.M., Quinn D.J., Hegarty S.M., Ward C., Walker B., Johnston J.A., Olwill S.A., Scott C.J. Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis. Clin. Cancer Res. 2009, 15:6042-6050.
9. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
10. Cambien B., Richard-Fiardo P., Karimdjee B.F., Martini V., Ferrua B., Pitard B., Schmid-Antomarchi H., Schmid-Alliana A. CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma. PLoS ONE 2011, 6:28842.
11. Conesa A., Götz S., García-Gómez J.M., Terol J., Talón M., Robles M. Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics 2005, 21:3674-3676.
12. Crews C.M., Erikson R.L. Purification of a murine protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product: relationship to the fission yeast byr1 gene product. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:8205-8209.
13. de Souza C.F., Xander P., Monteiro A.C., Silva A.G., da Silva D.C., Mai S., Bernardo V., Lopes J.D., Jasiulionis M.G. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis. PLoS ONE 2012, 7(9):e44880.
14. Gocheva V., Joyce J.A. Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 2007, 6:60-64.
15. Gray-Schopfer V., Wellbrock C., Marais R. Melanoma biology and new targeted therapy. Nature 2007, 22:851-857.
16. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
17. Hirano T., Ishihara K., Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000, 19:2548-2556.
18. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
19. Hussein M.R. Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity. Int. J. Exp. Pathol. 2006, 87:163-176.
20. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
21. Kogut M.H., Genovese K.J., He H., Kaiser P. Flagellin and lipopolysaccharide up-regulation of IL-6 and CXCLi2 gene expression in chicken heterophils is mediated by ERK1/2-dependent activation of AP-1 and NF-kappaB signaling pathways. Innate Immun. 2008, 14:213-222.
22. Kortylewski M., Jove R., Yu H. Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev. 2005, 24:315-327.
23. Kurosaka K., Takahashi M., Kobayashi Y. Activation of extracellular signal-regulated kinase 1/2 is involved in production of CXC-chemokine by macrophages during phagocytosis of late apoptotic cells. Biochem. Biophys. Res. Commun. 2003, 306:1070-1074.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
25. Levicar N., Strojnik T., Kos J., Dewey R.A., Pilkington G.J., Lah T.T. Lysosomal enzymes, cathepsins in brain tumour invasion. J. Neurooncol. 2002, 58:21-32.
26. Liu W., Spero D.M. Cysteine protease cathepsin S as a key step in antigen presentation. Drug News Perspect. 2004, 17:357-363.
27. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
28. Mantovani A. Cancer: inflaming metastasis. Nature 2009, 457:36-37.
29. Mi H., Muruganujan A., Thomas P.D. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 2012, 41:D377-D386.
30. Miller A.J., Mihm M.C. Melanoma. N. Engl. J. Med. 2006, 355:51-65.
31. Müller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verástegui E., Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
32. Nikolaou V.A., Stratigos A.J., Flaherty K.T., Tsao H. Melanoma: new insights and new therapies. J. Invest. Dermatol. 2012, 132:854-863.
33. Orgaz J.L., Sanz-Moreno V. Emerging molecular targets in melanoma invasion and metastasis. Pigment Cell Melanoma Res. 2013, 26:39-57.
34. Pérez E.C., Machado J., Aliperti F., Freymüller E., Mariano M., Lopes J.D. B-1 lymphocytes increase metastatic behavior of melanoma cells through the extracellular signal-regulated kinase pathway. Cancer Sci. 2008, 99:920-928.
35. Saeed A.I., Bhagabati N.K., Braisted J.C., Liang W., Sharov V., Howe E.A., Li J., Thiagarajan M., White J.A., Quackenbush J. TM4 microarray software suite. Methods Enzymol. 2006, 411:134-193.
36. Scotton C.J., Wilson J.L., Milliken D., Stamp G., Balkwill F.R. Epithelial cancer cell migration: a role for chemokine receptors?. Cancer Res. 2001, 61:4961-4965.
37. Spandidos A., Wang X., Wang H., Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 2010, 38:792-799.
38. Staquicini F.I., Moreira C.R., Nascimento F.D., Tersariol I.L., Nader H.B., Dietrich C.P., Lopes J.D. Enzyme and integrin expression by high and low metastatic melanoma cell lines. Melanoma Res. 2003, 13:11-18.
39. Staquicini F.I., Tandle A., Libutti S.K., Sun J., Zigler M., Bar-Eli M., Aliperti F., Pérez E.C., Gershenwald J.E., Mariano M., Pasqualini R., Arap W., Lopes J.D. A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. Cancer Res. 2008, 68:8419-8428.
40. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:4350-4354.
41. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:5116-5121.
42. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3:1-12.
43. Venkatasubbarao K., Choudary A., Freeman J.W. Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1. Acta Pharmacol. Sin. 2004, 25:1157-1164.
44. Venkatasubbarao K., Choudary A., Freeman J.W. Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases. Cancer Res. 2005, 65:2861-2871.
45. Viala E., Pouysségur J. Regulation of tumor cell motility by ERK mitogen-activated protein kinases. Ann. N. Y. Acad. Sci. 2004, 1030:208-218.
46. Waghray A., Keppler D., Sloane B.F., Schuger L., Chen Y.Q. Analysis of a truncated form of cathepsin H in human prostate tumor cells. J. Biol. Chem. 2002, 277:11533-11538.
47. Yang J., Chatterjee-Kishore M., Staugaitis S.M., Nguyen H., Schlessinger K., Levy D.E., Stark G.R. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res. 2005, 65:939-947.
48. Yang J., Liao X., Agarwal M.K., Barnes L., Auron P.E., Stark G.R. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 2007, 21:1396-1408.
49. Yang J., Stark G.R. Roles of unphosphorylated STATs in signaling. Cell Res. 2008, 18:443-451.
50. Yang S.F., Wang S.N., Wu C.F., Yeh Y.T., Chai C.Y., Chunag S.C., Sheen M.C., Lee K.T. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma. J. Clin. Pathol. 2007, 60:642-648.
51. Yu H., Marcin K., Drew P. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Tumour Immunol. 2007, 7:41-51.
52. Zebisch A., Czernilofsky A.P., Keri G., Smigelskaite J., Sill H., Troppmair J. Signaling through RAS-RAF-MEK-ERK: from basics to bedside. Curr. Med. Chem. 2007, 14:601-623.